Navigation Links
Scent To Sleep All Natural Non-Drowsy Sleep Mist Acquired by Innovative Custom Products, Inc. (ICP)
Date:4/20/2009

"We love Scent To Sleep products so much, we bought the company"

MILWAUKEE, April 20 /PRNewswire/ -- Innovative Custom Products, Inc. (ICP) announced today that ICP has acquired Scent To Sleep - a California company. Scent To Sleep manufactures and distributes a revolutionary All Natural Non-Drowsy Sleep Mist (www.ScentToSleep.com).

According to Sherry Williams, Senior VP, "We love Scent To Sleep products so much, we bought the company. Scent To Sleep is so easy to use and really gets the job done. By simply applying 3 to 5 sprays on your pillow, bed, pajamas, or in the bedroom five minutes before bedtime, you will feel relaxed, and go right to sleep...and the best part is you wake up feeling refreshed and energized."

Scent To Sleep is all natural, safe, environmentally friendly, and one of the most innovative non-prescription sleep aids to hit the market. Its proprietary formulation contains no chemicals or harmful ingredients, has no horrible prescription side effects, and you never have to take a pill.

According to Sherry, consumers love this product too! "With one exposure in Woman's World Magazine, sales increased ten-fold." Scent To Sleep is expected in some retail chains later this year. In the meantime, consumers can purchase Scent To Sleep at www.drmistICP.com, the corporation's ecommerce website. Scent To Sleep is available in Luscious Lavender Scent and Decadent Green Apple with Vanilla, backed by the company's 100% Money-Back Guarantee, and retails for $11.99.

The company is currently offering a 2-for-1 National TV Promotional Special as a way to introduce Scent To Sleep to the public. Simply visit www.drmistICP.com and order Scent To Sleep and a second bottle will be shipped FREE with your order.

'/>"/>
SOURCE Innovative Custom Products, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. University HealthSystem Consortium Names Ascent Healthcare Solutions Supplier of the Year at UHC 2009 Performance Excellence Forum
2. AUDIO from Medialink and Forest Pharmaceuticals: FDA Approves Lexapro for Major Depressive Disorder in Adolescents
3. CVS Caremark Study Documents Changes in Prescription Drug Use to Treat High Blood Pressure, High Cholesterol and Diabetes in Children and Adolescents
4. Gaining new insights into mentoring programs for adolescent girls
5. Naturally fluorescent molecules may serve as cancer biomarker
6. Task Force Recommends Screening Adolescents for Clinical Depression
7. Forest Laboratories, Inc. Announces FDA Approval of Lexapro(R) for the Treatment of Major Depressive Disorder in Adolescents
8. Study finds most adolescents sent to group homes still involved with drugs/crime seven years later
9. Society for Adolescent Medicine Meeting to Focus on E-Teens and How Adolescents Incorporate Technology and Health
10. Reducing suicidal behaviors among adolescents
11. New Research Released at Annual Society for Adolescent Medicine Meeting Provides Vital Insights into Adolescent Health Issues

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...TRIANGLE PARK, N.C., Dec. 1 Max Ne...have expanded over the years serving the top most ...ich was originally set up in an area of 2000 sq. f...part of the suite of services by Max Neeman, are r...ble offering. ,, The pharmacy inventory managem...
(Date:12/1/2009)... Dec. 1 Individuals in ...ly than those with traditional coverage to exhibit...engaged in wellness programs, and to be more incli...olding down costs, according to survey results rel...search Institute (EBRI). ,, At the same time, ...
(Date:12/1/2009)...RDALE, Fla., Dec. 1 OrbusNeich tod...in the randomized clinical trial of the Combo Bio-...,, A prospective, randomized, multicenter study...u M inal sirolimus coat ED bio- E ngineered...ites in Asia, Australia, Europe and South America ...
(Date:12/1/2009)...California are unable to successfully obtain infor... despite recent state legislation intended to impr..., Posing as low-income uninsured patients, resea...-third of the hospitals they approached and the es... allowed under California law, according to the fi...
(Date:12/1/2009)... Lumension announces general availability of its ...ver end-to-end endpoint management capabilities on...nt console architecture. , ...sion, a global leader in endpoint management and s...dpoint Management and Security Suite (LEMSS) tha...
Breaking Medicine News(10 mins):Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 2Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 3Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 4Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 4Health News:Hospital price transparancy laws in California fall short, study finds 2Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 2Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 3Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 4Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 5Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 6
...lease is available in French . , A collaborati...ogical Institute (MNI), McGill University has demo... and cortical thickness in the brains of healthy 6... week in a special issue of scientific journal In...
...Texas, March 25 ULURU Inc. (NYSE Alternext: ULU) ...ce call to discuss the fourth quarter and year end...siness update on Tuesday, March 31, 2009 at 10:00 ...304#) five to ten minutes prior to the initiation ...
...e Call Today to Follow Release , , DENVER, March ... or the "Company") (OTC Bulletin Board: GLOB), an ...logy company, will report its fourth quarter and y...p://www.newscom.com/cgi-bin/prnh/20040226/GLOBALME...
...tive growths 3 times more likely regardless of age...h 25 (HealthDay News) -- Black women are three tim...p aggressive breast cancer, a U.S. study finds. , ...k women do get breast cancer, it,s often more adva...
...y 20 March, US researcher Dr. Chris Beecher from t...ture about sarcosine, an N-methyl derivative of th...ess in Stockholm, Sweden. Dr Beecher is a colleagu... with prostate cancer. These findings suggest that...
... March 25 An amazing medical discovery that provi... (ED) is in the US and looking to make the big th... News Release, go to: http://www.prnewswire.com/m...te Hydropump reverses Erectile Dysfunction throu...
Other Medicine News:Health News:When it comes to intelligence, size matters 2Health News:ULURU Inc. Announces Conference Call to Discuss Financial Results for the Fourth Quarter and Year Ended December 31, 2008 and to Provide a Business Update 2Health News:Global Med Technologies(R), Inc. to Report Fourth Quarter and Year End Financial Results Today 2Health News:Black Women at Higher Risk for Aggressive Breast Tumors 2Health News:A new approach to prostate cancer detection 2Health News:Video: Bathmate Hydropump Poised to Replace Cialis, Levitra, and Viagra 2
(Date:12/1/2009)..., , ALBUQUERQUE, N.M., Dec. 1 /PRNewswire/ -...s laboratory that discovers, develops and markets ...ointment of Scott Glenn as chairman of the company... ,, Prior to joining Exagen, Glenn was managing... of a number of successful biomedical companies in...
(Date:12/1/2009)..., , CHENGDU, China, Dec. 1 /PRNews..., Inc., (NYSE Amex: TPI ), a manufacturer and sup..."TCM") based in Chengdu, China, today,announced th...e Food and Drug,Administration (SFDA) to produce P...m of 10 ml/tube (SFDA approval number Z20093060) a...
(Date:12/1/2009)..., , BEIJING, Dec. 1 /PRNewswire-A...ding provider of biopharmaceutical products in Chi...h purchase order for its H1N1 vaccine, PANFLU.1(TM...on Technology for the national,purchase plan. Unde...uce an,additional one million doses of PANFLU.1 (T...
Breaking Medicine Technology:Scott Glenn Joins Exagen Diagnostics as Chairman and CEO 2Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA New Product Approvals for 2 Generic Products 2Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA New Product Approvals for 2 Generic Products 3Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 2Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 3Selective Insurance Group Announces Officer Appointments 56161 1Selective Insurance Group Announces Officer Appointments 56161 2Selective Insurance Group Announces Officer Appointments 56161 3XLHealth Appoints New Controller to Lead Financial Compliance Accounting Initiatives 56160 1XLHealth Appoints New Controller to Lead Financial Compliance Accounting Initiatives 56160 2Kroger Selects WaveSense Diabetes Testing Products 56156 1Kroger Selects WaveSense Diabetes Testing Products 56156 2
...N DIEGO, July 28 Cadence Pharmaceuticals,Inc. (Na... on in-licensing,developing and commercializing pr...n the hospital setting, today announced that it wi...fore the market opens on Thursday,August 7, 2008.,...nd live webcast to,discuss the financial results a...
...Two Large-Scale Analyses Have Conflicting Results ...in memory and thinking processes among placebo gro...educe the ability to show the effectiveness,of new...ported today at the,2008 Alzheimer,s Association I...AD 2008) in Chicago., Alzheimer clinical trials s...
Other Medicine Technology:Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008 2Controversy About Lack of Placebo Group Decline in Alzheimer's Clinical Trials 2Controversy About Lack of Placebo Group Decline in Alzheimer's Clinical Trials 3Controversy About Lack of Placebo Group Decline in Alzheimer's Clinical Trials 4Controversy About Lack of Placebo Group Decline in Alzheimer's Clinical Trials 5
... - Our networked solutions are delivered with a Ma...Never purchase software upgrades again; utilize ou...e ever-changing needs of your healthcare facility....tments have a mix of old and new equipment; we use...
...logy is the first digital solution designed specif...s both within and outside cardiology. From the ser...ions, Agfas combined expertise in both cine film a...to work the way they want, wherever they want.,Th...
Full Digital Ultrasound System UF-850XTD
Nemio
Medicine Products: